At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Mar 18, 2026 at 16:59 ET
Analysis based on filing metadata only, document content was unavailable. This DEFA14A filing by Boston Scientific Corp (BSX) relates to a proxy statement for a shareholder vote, likely concerning director elections, executive compensation, or other corporate governance matters. Without access to the full filing, specific details on proposals or activist involvement cannot be determined.
- Filing type DEFA14A indicates this is a definitive proxy statement for a shareholder meeting.
- Typically includes information on director nominees, executive compensation, and shareholder proposals.
- No document content available to confirm specific agenda items or voting recommendations.
- Recent insider buying observed in congressional trades, though not necessarily linked to this filing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access